Total planned funding: $390,061,272
Allocations
Countries/Regions
| Eswatini | $390,061,272 |
Organizational Types
| Private Contractor | $93,203,350 |
| Unknown | $78,182,628 |
| NGO | $69,491,980 |
| University | $65,849,114 |
| Own Agency | $45,312,187 |
| Multi-lateral Agency | $14,074,056 |
| Host Country Government Agency | $10,559,094 |
| FBO | $9,407,717 |
| Other USG Agency | $3,341,146 |
| Implementing Agency | $640,000 |
Program Areas
| Care | $123,461,354 |
| Treatment | $88,955,151 |
| Prevention | $73,676,864 |
| Governance and Systems | $48,444,331 |
| Testing | $30,355,198 |
| Management and Operations | $25,168,374 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $65,072,529 |
| HBHC: Care: Adult Care and Support | $54,031,105 |
| HKID: Care: Orphans and Vulnerable Children | $37,221,475 |
| HVCT: Testing: HIV Testing and Counseling | $30,355,198 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $27,645,677 |
| HVMS: Management and Operations | $25,168,374 |
| HVSI: Strategic Information | $24,770,451 |
| HVTB: Care: TB/HIV | $21,661,479 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $19,743,656 |
| OHSS: Health Systems Strengthening | $17,797,549 |
| HTXD: Treatment: ARV Drugs | $16,663,808 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,112,622 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,846,152 |
| PDCS: Care: Pediatric Care and Support | $10,547,295 |
| PDTX: Treatment: Pediatric Treatment | $7,218,814 |
| HLAB: Laboratory Infrastructure | $5,876,331 |
| HMBL: Biomedical Prevention: Blood Safety | $1,328,757 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$73,280,655
Countries/Regions
Columbia University:
$54,909,685
Countries/Regions
Pact, Inc.:
$41,019,976
Countries/Regions
USG Aggregated Agencies:
$25,403,211
Countries/Regions